IHS Chemical Week

World News and Views :: Top of the News

Merck KGaA terminates license agreement with Japanese pharma producer

8:21 AM MDT | June 17, 2014 | Natasha Alperowicz

Merck KGaA announced today that it has reached a mutual agreement with Ono Pharmaceutical (Osaka) to terminate a license agreement for ceralifimod (ONO-4641) because it does not meet Merck’s threshold for continued investment. Merck obtained the worldwide, exclusive license rights from Ono Pharmaceutical for the development and commercialization of ONO-4641 in multiple sclerosis (MS) outside of Japan, Korea, and Taiwan in October 2011. The drug candidate is currently in phase-two clinical development.   Merck says its biopharmaceutical division, Merck...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa